Follow the 피씨엘 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 피씨엘 has recorded 39 insider filings. The latest transaction was reported on 19 November 2024 (Purchase). Among the most active insiders: 김소연. All data is accessible without an account.
39
Insider Decl.
n/a
Thresholds
n/a
18 ops.
Buy Volume
n/a
2 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
피씨엘 is a company specializing in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative diagnostic solutions.